Phathom Pharmaceuticals Inc (PHAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,665 | -143,883 | -108,057 | -71,395 | -34,843 |
| Depreciation Amortization | 646 | 4,116 | 3,474 | 954 | 489 |
| Other Working Capital | -11,952 | -27,315 | -15,938 | -16,283 | -19,586 |
| Other Operating Activity | 7,214 | 18,625 | 13,326 | 8,595 | 4,175 |
| Operating Cash Flow | $-44,757 | $-148,457 | $-107,195 | $-78,129 | $-49,765 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -67 | -328 | -228 | -214 | -169 |
| Investing Cash Flow | $-67 | $-328 | $-228 | $-214 | $-169 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 96,889 | 96,889 | N/A | N/A |
| Debt Repayment | N/A | -54,125 | -54,125 | N/A | N/A |
| Common Stock Issued | N/A | 1,944 | 1,781 | 516 | 412 |
| Financing Cash Flow | $0 | $44,708 | $44,545 | $516 | $412 |
| Beginning Cash Position | 183,419 | 287,496 | 287,496 | 287,496 | 287,496 |
| End Cash Position | 138,595 | 183,419 | 224,618 | 209,669 | 237,974 |
| Net Cash Flow | $-44,824 | $-104,077 | $-62,878 | $-77,827 | $-49,522 |
| Free Cash Flow | |||||
| Operating Cash Flow | -44,757 | -148,457 | -107,195 | -78,129 | -49,765 |
| Capital Expenditure | -67 | -328 | -228 | -214 | -169 |
| Free Cash Flow | -44,824 | -148,785 | -107,423 | -78,343 | -49,934 |